Ex vivo expansion of mafosfamide-purged PBPC products-Reference-Cited by-同舟云学术

Ex vivo expansion of mafosfamide-purged PBPC products

Published:2006 Issue:5 Volume:8 Page:459-464
ISSN:1465-3249
Container-title:Cytotherapy
language:en
Short-container-title:Cytotherapy

Author:

McNiece I.,Civin C.,Harrington J.,Kellner J.,Malehorn M.,Turney J.,Barber J.,Jones R.

Publisher

Elsevier BV

Subject

Cancer Research,Transplantation,Cell Biology,Genetics(clinical),Oncology,Immunology,Immunology and Allergy

Reference22 articles.

1. Elimination of acute myelogenous leukemic cells from marrow and tumor suspensions in the rat with 4-hydroperoxycyclophosphamide;Sharkis;Blood,1980

2. Autologous bone marrow transplantation in patients with acute nonlymphocytic leukemia, using ex vivo marrow treatment with 4- hydroperoxycyclophosphamide;Yeager;N Engl J Med,1986

3. The effect of graft purging with 4-hydroperoxycyclophosphamide in autologous bone marrow transplantation for acute myelogenous leukemia;Miller;Exp Hematol,2001

4. Autologous bone marrow transplantation for acute myeloblastic leukemia in Europe: further evidence of the role of marrow purging by mafosfamide. European Co-operative Group for Bone Marrow Transplantation (EBMT);Gorin;Leukemia,1991

5. Autologous bone marrow transplantation for acute myelocytic leukemia in first remission: a European survey of the role of marrow purging;Gorin;Blood,1990

Cited by 2 articles. 订阅此论文施引文献订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献

1. The ex vivo purge of cancer cells using oncolytic viruses: recent advances and clinical implications;Oncolytic Virotherapy;2015-01

2. Regenerative Medicine Applications in Hematology;Fundamentals of Tissue Engineering and Regenerative Medicine